Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quoin Pharmaceuticals, Ltd. (QNRX) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Quoin Pharmaceuticals, Ltd.. Table 2 shows the detailed insider transactions. This company's CIK number is 1671502.
Total stock buying since 2024: $79,292.
Total stock sales since 2024: $217.
Total stock option exercises since 2024: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 104,485 | $79,292 | 297 | $217 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-09 | 104,485 | $79,292 | 0 | $0 | 0 | $0 |
| 2024-06 | 0 | $0 | 297 | $217 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-10 | Dunn Gordon (Chief Financial Officer) | Buy | 20,000 | .81 | 16,200 |
| 2024-09-09 | Dunn Gordon (Chief Financial Officer) | Buy | 8,856 | .79 | 7,022 |
| 2024-09-04 | Myers Michael (Chief Executive Officer) | Buy | 37,094 | .73 | 27,226 |
| 2024-09-04 | Carter Denise P. (Chief Operating Officer) | Buy | 31,813 | .77 | 24,559 |
| 2024-09-03 | Myers Michael (Chief Executive Officer) | Buy | 800 | .62 | 495 |
| 2024-09-03 | Carter Denise P. (Chief Operating Officer) | Buy | 5,922 | .64 | 3,790 |
| 2024-06-07 | Langer Dennis | Sale | 297 | .73 | 217 |
Insider trading activities including stock purchases, stock sales, and option exercises of QNRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Quoin Pharmaceuticals, Ltd. (symbol QNRX, CIK number 1671502) see the Securities and Exchange Commission (SEC) website.